PAHC Stock Gains From Innovation, Market Expansion Goal
Phibro(PAHC) ZACKS·2024-09-14 00:06
Phibro Animal Health's (PAHC) diversified product portfolio and wide presence in key growth areas bolster our confidence in the stock. The stock carries a Zacks Rank #2 (Buy) currently. Factors Driving PAHC's Growth Phibro's key animal health products, including Medicated Feed Additives (MFAs) and nutritional specialty products, enhance animal nutrition. The company's leading product franchise, Stafac/V-Max/Eskalin, is approved in more than 30 countries for use in poultry and swine. Similarly, the company's ...